OBJECTIVES: To investigate the epidemiology and risk factors of gonorrhoea (GC) or chlamydia (CT) coinfection in an HIV-positive US military cohort, focusing on the time after participants' knowledge of HIV diagnosis. METHODS: The authors analysed data from 4461 participants enrolled in the U.S. Military Natural History Study cohort for GC or CT infection ≥6 months after their HIV-positive test. RESULTS: During a mean follow-up of 7.08 years, 482 (11%) participants acquired a GC or CT infection. Of these, 283 (6%) acquired a GC infection, 278 (6%) acquired a CT infection and 123 (3%) had multiple GC or CT infections during follow-up. Risk of GC or CT infection was significantly greater in those younger, male, African-American and with a history of GC or CT infection. CONCLUSIONS: Frequent GC and CT diagnoses observed among members of this HIV-positive cohort indicate substantial ongoing risk behaviours that raise concerns for HIV transmission and underscore the need for continued screening to help identify and treat these sexually transmitted infections in this population.
OBJECTIVES: To investigate the epidemiology and risk factors of gonorrhoea (GC) or chlamydia (CT) coinfection in an HIV-positive US military cohort, focusing on the time after participants' knowledge of HIV diagnosis. METHODS: The authors analysed data from 4461 participants enrolled in the U.S. Military Natural History Study cohort for GC or CT infection ≥6 months after their HIV-positive test. RESULTS: During a mean follow-up of 7.08 years, 482 (11%) participants acquired a GC or CT infection. Of these, 283 (6%) acquired a GC infection, 278 (6%) acquired a CT infection and 123 (3%) had multiple GC or CT infections during follow-up. Risk of GC or CT infection was significantly greater in those younger, male, African-American and with a history of GC or CT infection. CONCLUSIONS: Frequent GC and CT diagnoses observed among members of this HIV-positive cohort indicate substantial ongoing risk behaviours that raise concerns for HIV transmission and underscore the need for continued screening to help identify and treat these sexually transmitted infections in this population.
Authors: Julia R Raifman; Kelly A Gebo; William Christopher Mathews; Philip Todd Korthuis; Khalil G Ghanem; Judith A Aberg; Richard D Moore; Ank E Nijhawan; Anne K Monroe; Stephen A Berry Journal: J Acquir Immune Defic Syndr Date: 2017-12-01 Impact factor: 3.731
Authors: Julia M Skinner; Jana Distefano; Jennifer Warrington; S Robert Bailey; Michelle Winscott; Melanie M Taylor Journal: Public Health Rep Date: 2014 Jan-Feb Impact factor: 2.792
Authors: Brian K Agan; Anuradha Ganesan; Morgan Byrne; Robert Deiss; Christina Schofield; Ryan C Maves; Jason Okulicz; Xiuping Chu; Thomas O'Bryan; Tahaniyat Lalani; Karl Kronmann; Tomas Ferguson; Merlin L Robb; Timothy J Whitman; Timothy H Burgess; Nelson Michael; Edmund Tramont Journal: Mil Med Date: 2019-11-01 Impact factor: 1.437
Authors: Leonard Emuren; Seth Welles; Grace Macalino; Alison A Evans; Marcia Polansky; Anuradha Ganesan; Rhonda E Colombo; Brian K Agan Journal: Qual Life Res Date: 2020-02-20 Impact factor: 4.147
Authors: David W Purcell; Yoko Mizuno; Dawn K Smith; Kristina Grabbe; Cari Courtenay-Quick; Hank Tomlinson; Jonathan Mermin Journal: Arch Sex Behav Date: 2014-01
Authors: Robert J Carpenter; Oliver N Refugio; Nehkonti Adams; Kevin P O'Brien; Mark D Johnson; Harold L Groff; Ryan C Maves; Mary F Bavaro; Nancy F Crum-Cianflone Journal: BMJ Open Date: 2013-05-28 Impact factor: 2.692
Authors: Ann N Burchell; Ramandip Grewal; Vanessa G Allen; Sandra L Gardner; Veronika Moravan; Ahmed M Bayoumi; Rupert Kaul; Frank McGee; Margaret Peggy E Millson; Robert S Remis; Janet Raboud; Tony Mazzulli; Sean B Rourke Journal: Sex Transm Infect Date: 2014-09-01 Impact factor: 3.519